DYSLIPIDEMIA
Clinical trials for DYSLIPIDEMIA explained in plain language.
Never miss a new study
Get alerted when new DYSLIPIDEMIA trials appear
Sign up with your email to follow new studies for DYSLIPIDEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a digital tool help doctors prescribe the perfect workout for heart patients?
Disease control Recruiting nowThis study tests a new digital tool that helps doctors create personalized exercise plans for people with heart disease risk factors like high blood pressure, diabetes, and obesity. About 72 patients and 24 doctors will take part. The goal is to see if the tool is easy to use and…
Matched conditions: DYSLIPIDEMIA
Phase: NA • Sponsor: University of Connecticut • Aim: Disease control
Last updated May 26, 2026 02:34 UTC
-
Soy swap diet tested to tame blood pressure in diabetes
Disease control Recruiting nowThis study tests whether a digital diet program, combined with extra vegetables and soy foods, can lower blood pressure in adults with hypertension, obesity, and type 2 diabetes. 300 participants will be split into three groups: one gets highly processed soy foods, another gets m…
Matched conditions: DYSLIPIDEMIA
Phase: NA • Sponsor: University of Toronto • Aim: Disease control
Last updated May 26, 2026 02:32 UTC
-
Can a cholesterol drug shrink artery plaque in diabetes patients?
Disease control Recruiting nowThis study tests whether choline fenofibrate, a drug that lowers fats in the blood, can reduce plaque buildup in the neck arteries of people with type 2 diabetes and mixed high cholesterol. About 56 adults will receive either choline fenofibrate or a comparison drug (policosanol)…
Matched conditions: DYSLIPIDEMIA
Phase: PHASE4 • Sponsor: Seoul National University Bundang Hospital • Aim: Disease control
Last updated May 26, 2026 02:30 UTC
-
New combo pill aims to tackle diabetes and cholesterol in one go
Disease control Recruiting nowThis study tests a new drug, CMG190303, in 240 adults with type 2 diabetes and high cholesterol. It compares the drug's effect on blood sugar and cholesterol levels against standard treatments. The goal is to see if the new drug works better and is safe.
Matched conditions: DYSLIPIDEMIA
Phase: PHASE3 • Sponsor: CMG Pharmaceutical Co. Ltd • Aim: Disease control
Last updated May 26, 2026 02:26 UTC
-
Step up for health: new study tests tailored walking prescriptions for weight loss
Disease control Recruiting nowThis study aims to see if prescribing a specific number of daily steps based on a person's weight and body fat can help overweight or obese adults lose weight and improve heart health. Researchers will first develop a formula to predict weight loss from step counts, then test it …
Matched conditions: DYSLIPIDEMIA
Phase: NA • Sponsor: Kennesaw State University • Aim: Disease control
Last updated May 26, 2026 02:25 UTC
-
Can a phone app help prevent heart attacks? new study seeks answers
Disease control Recruiting nowThis study tests whether a digital heart health program (app and online sessions) added to usual care can lower cholesterol and reduce heart attacks, strokes, and other major heart events over 7 years. About 1,100 adults with heart disease or high risk factors who are already on …
Matched conditions: DYSLIPIDEMIA
Phase: NA • Sponsor: University of Toronto • Aim: Disease control
Last updated May 22, 2026 14:01 UTC
-
Cottonseed oil: the surprising weekly heart helper?
Disease control Recruiting nowThis study looks at whether drinking cottonseed oil just three times a week can lower cholesterol and other heart disease risks. Researchers will compare two different amounts of the oil against a no-oil group in 75 adults who are overweight or have high cholesterol. Participants…
Matched conditions: DYSLIPIDEMIA
Phase: NA • Sponsor: University of Georgia • Aim: Disease control
Last updated May 20, 2026 11:57 UTC
-
New study tests structured plan to tame heart risks
Disease control Recruiting nowThis study looks at whether a structured clinical and medication management plan can improve heart health in adults with risk factors like high blood pressure, diabetes, and high cholesterol. Researchers will track 220 patients in a regular cardiology clinic to see if this approa…
Matched conditions: DYSLIPIDEMIA
Phase: NA • Sponsor: Universidad Católica San Antonio de Murcia • Aim: Disease control
Last updated May 18, 2026 12:12 UTC
-
New combo pill aims to tackle two heart risks at once
Disease control Recruiting nowThis study tests whether taking two medications together (JW0104 and C2402) is safe and effective for people with both high blood pressure and high cholesterol. About 162 adults will receive either the combo or a placebo. The goal is to see if the combo lowers blood pressure and …
Matched conditions: DYSLIPIDEMIA
Phase: PHASE3 • Sponsor: JW Pharmaceutical • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
Shanghai study to track 4,000 adults for Decade-Long health insights
Knowledge-focused Recruiting nowThis study follows over 4,000 adults from Shanghai communities to track how heart, kidney, and metabolic diseases develop and change over time. Participants were first checked between 2016-2017 and will be re-assessed through 2035. The goal is to understand risk factors and impro…
Matched conditions: DYSLIPIDEMIA
Sponsor: Shanghai Changzheng Hospital • Aim: Knowledge-focused
Last updated May 26, 2026 02:33 UTC
-
Can a new program finally get chronic disease patients to stick to healthy habits?
Knowledge-focused Recruiting nowThis study looks at why people with chronic conditions like high blood pressure, diabetes, and high cholesterol often struggle to adopt healthy behaviors, even when they know it's important. Researchers will test a program designed to boost motivation and help patients take charg…
Matched conditions: DYSLIPIDEMIA
Phase: NA • Sponsor: Xiong Juyang • Aim: Knowledge-focused
Last updated May 26, 2026 02:20 UTC
-
New drug AZD4954 enters first human tests for cholesterol and lp(a) conditions
Knowledge-focused Recruiting nowThis early-stage study tests the safety and tolerability of a new drug called AZD4954 in healthy volunteers and people with high Lp(a) or dyslipidemia (abnormal cholesterol levels). About 136 participants will receive either the drug or a placebo to see how the body processes it …
Matched conditions: DYSLIPIDEMIA
Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated May 22, 2026 13:53 UTC
-
Healthy volunteers needed to test drug combo for cholesterol
Knowledge-focused Recruiting nowThis study tests two experimental drugs for high cholesterol (dyslipidemia) in 50 healthy adults. The goal is to see how the drugs interact when taken together and check for side effects. Participants will take each drug alone and then both together. This is an early-stage study …
Matched conditions: DYSLIPIDEMIA
Phase: PHASE1 • Sponsor: Korea United Pharm. Inc. • Aim: Knowledge-focused
Last updated May 22, 2026 13:52 UTC
-
NIH launches Long-Term study on rare genetic fat conditions
Knowledge-focused Recruiting nowThis study aims to learn more about rare genetic disorders that affect fat levels in the blood, such as too much or too little cholesterol or triglycerides. Researchers will follow 1,500 people aged 10 and older for up to 20 years to see how these conditions change and respond to…
Matched conditions: DYSLIPIDEMIA
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated May 18, 2026 12:12 UTC